ghk cu fda approved drug adds non-injectable GHK-Cu back to Category 1. FDA Thursday re-added non-injectable GHK-Cu to Category 1 of the 503A bulks process after the nomination was withdrawn from further review. Injectable GHK-Cu remains Buy GHK-Cu (50mg) | Order
Description
This substrate site-targeting mechanism provides selectivity over related methyltransferases and other NAD salvage pathway enzymes in laboratory assay systems

Months 7-11: Approaching plateau

Novo Nordisk filed a New Drug Application with the FDA for CagriSema in late December

J.BeardwellC
The Wolverine stack One such compound, first discovered in human gastric juice, that is attracting lots of attention is BPC-157
